Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.54 | 0.0003 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0006 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.003 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.007 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |